Home/Filings/5/0001959675-26-000001
5//SEC Filing

Covelens Courtney Lee 5

Accession 0001959675-26-000001

CIK 0000750558other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 2:36 PM ET

Size

35.2 KB

Accession

0001959675-26-000001

Insider Transaction Report

Form 5
Period: 2025-12-31
Covelens Courtney Lee
EVP, Chief Retail Officer
Transactions
  • Purchase

    Common Stock

    [F1]
    2025-03-28$34.94/sh+29.472$1,0302,739.346 total
  • Purchase

    Common Stock

    [F2]
    2025-05-30$28.80/sh+198$5,7022,937.346 total
  • Purchase

    Common Stock

    [F1]
    2025-06-27$33.52/sh+33.299$1,1162,970.645 total
  • Purchase

    Common Stock

    [F1]
    2025-09-26$35.47/sh+31.826$1,1293,002.471 total
  • Purchase

    Common Stock

    [F2]
    2025-11-28$29.81/sh+197$5,8733,199.471 total
  • Purchase

    Common Stock

    [F1]
    2025-12-26$34.91/sh+34.827$1,2163,234.297 total
Holdings
  • Common Stock(Right to Buy)

    Exercise: $32.50From: 2024-02-15Exp: 2026-02-15Common Stock (750 underlying)
    750
  • Common Stock(Right to Buy)

    Exercise: $37.26From: 2025-02-15Exp: 2027-02-15Common Stock (1,000 underlying)
    1,000
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2024-02-15Exp: 2033-02-15Common Stock (700 underlying)
    700
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2025-02-15Exp: 2033-02-15Common Stock (700 underlying)
    700
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2026-02-15Exp: 2033-02-15Common Stock (700 underlying)
    700
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2027-02-15Exp: 2033-02-15Common Stock (700 underlying)
    700
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2028-02-15Exp: 2033-02-15Common Stock (700 underlying)
    700
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2025-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2026-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2027-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2028-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2029-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2026-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2027-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2028-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2029-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2030-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
Footnotes (2)
  • [F1]Dividend Reinvestment Plan Acquisition
  • [F2]Employee Stock Purchase Plan Acquisition
Signature
Courtney L Covelens|2026-01-27

Issuer

QNB CORP.

CIK 0000750558

Entity typeother

Related Parties

1
  • filerCIK 0001959675

Filing Metadata

Form type
5
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 2:36 PM ET
Size
35.2 KB